Which has the lower trailing P/E, CBNK or DMII?

CBNK has the lower trailing P/E: CBNK trades at 11.81 and DMII at 34.77. P/E is one valuation measure and does not by itself establish which business is cheaper.

Does CBNK or DMII pay a bigger dividend?

CBNK pays a dividend (1.25% yield), while DMII has no payments in the available dividend history.

Is CBNK or DMII more profitable?

CBNK runs the higher net margin — CBNK at 19.26% versus DMII at 0.00%.

Capital Bancorp, Inc. (CBNK) vs Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII)

A side-by-side comparison of Capital Bancorp, Inc. and Drugs Made In America Acquisition II Corp. Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CBNK

Capital Bancorp, Inc.

$654M

$40.15Financial ServicesDelayed quote: Oct 6, 2026, 10:35 AM EDT

DMII

Drugs Made In America Acquisition II Corp. Ordinary Shares

$649M

$10.19Financial ServicesDelayed quote: Oct 6, 2026, 10:28 AM EDT

Total return — CBNK vs DMII

growth of $100 · dividends reinvested · last 1y

CBNK +41.2% (+41.2%/yr)DMII +3.1% (+3.1%/yr)CBNK compounded faster over this window

CBNK DMII

CBNK vs DMII: by the numbers

•CBNK is the larger company ($654M vs $649M market cap).
•CBNK trades at the lower trailing earnings multiple (11.81 vs 34.77 P/E), one valuation lens rather than an overall verdict.
•CBNK is profitable (19.26% net margin) while DMII runs a net loss (0.00%).
•CBNK pays a dividend (1.25% yield), while DMII has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	CBNK	DMII
P/E ratio	11.81	34.77
Forward P/E	11.54	N/A
PEG ratio	0.93	N/A
P/S ratio	2.23	N/A
P/B ratio	1.55	1.31

Profitability

Metric	CBNK	DMII
Gross margin	N/A	0.00%
Operating margin	15.76%	0.00%
Net margin	19.26%	0.00%
ROE	13.35%	2.62%
ROIC	N/A	-0.28%

Capital Bancorp, Inc.: Gross margin is not shown for a lender or insurer: its revenue is interest, premiums and fees rather than the sale of goods, so there is no cost of goods sold to measure it against.

Dividends

Metric	CBNK	DMII
Dividend yield	1.25%	N/A
Payout ratio	14.71%	N/A

Growth (annualized)

Metric	CBNK	DMII
Revenue CAGR (5Y)	10.99%	N/A
EPS CAGR (5Y)	13.03%	N/A
Total return CAGR (5Y)	11.49%	N/A

Frequently asked

Which has the lower trailing P/E, CBNK or DMII?: CBNK has the lower trailing P/E: CBNK trades at 11.81 and DMII at 34.77. P/E is one valuation measure and does not by itself establish which business is cheaper.
Does CBNK or DMII pay a bigger dividend?: CBNK pays a dividend (1.25% yield), while DMII has no payments in the available dividend history.
Is CBNK or DMII more profitable?: CBNK runs the higher net margin — CBNK at 19.26% versus DMII at 0.00%.

Go deeper

Full CBNK analysis Full DMII analysis Interactive comparison tool

Dig into the metrics

Capital Bancorp P/E ratio Drugs Made In America Acquisition II Corp. Ordinary Shares P/E ratio Capital Bancorp dividend yield Capital Bancorp ROE Drugs Made In America Acquisition II Corp. Ordinary Shares ROE Capital Bancorp operating margin Drugs Made In America Acquisition II Corp. Ordinary Shares operating margin Capital Bancorp revenue growth Drugs Made In America Acquisition II Corp. Ordinary Shares revenue growth Drugs Made In America Acquisition II Corp. Ordinary Shares free cash flow

Capital Bancorp & Drugs Made In America Acquisition II Corp. Ordinary Shares appear in these rankings

Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.